Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00160017
Status:
COMPLETED
Last Update Posted:
2015-11-30
First Post:
2005-09-09
Brief Title:
Effectiveness and Cost-effectiveness of the Diabetes Integrated Care Breakthrough Collaborative
Sponsor:
Radboud University Medical Center
Organization:
Radboud University Medical Center
Study Overview
Official Title:
Effectiveness and Cost-effectiveness of the Diabetes Integrated Care Breakthrough Collaborative to Improve Diabetes Care Its Health Outcomes and Economic Costs
Status:
COMPLETED
Status Verified Date:
2015-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study tests whether implementing professional evidence-based guidelines and best practices for diabetes care -through participation of multidisciplinary teams in a Breakthrough collaborative- results in an improvement of diabetes care its health outcomes and economic costs Determinants of success are studied Data on diabetes will also be used to better understand Breakthrough as an implementation or improvement method
Detailed Description:
Diabetes mellitus as a chronic disease is a major and growing health care problem Studies on the prevention of severe complications provide evidence for the necessity of tight control Different interventions and models to achieve strict control and reduce diabetes related risks of complications are available These are however not implemented in daily practice Our study focuses on this implementation problem it tests whether implementing professional evidence-based guidelines and best practices -through participation of multidisciplinary teams in the Breakthrough collaborative- results in an improvement of diabetes care its health outcomes and economic costs
Data on diabetes will also be used to explore and better understand the Breakthrough model as an implementation method Only uncontrolled observational studies have so far described the outcomes of Breakthrough collaboratives They also describe significant differences between teams in specific improvements made in patient care and organisational performance resulting in different implementation and medical costs There is hardly any information regarding these costs and the cost-effectiveness of collaboratives and little knowledge about how they could be made more effective Insight is also needed into the factors that influence the success of individual teams There are no data regarding the sustainability of improvements
Data on diabetes will also be used to explore and better understand the Breakthrough model as an implementation method Only uncontrolled observational studies have so far described the outcomes of Breakthrough collaboratives They also describe significant differences between teams in specific improvements made in patient care and organisational performance resulting in different implementation and medical costs There is hardly any information regarding these costs and the cost-effectiveness of collaboratives and little knowledge about how they could be made more effective Insight is also needed into the factors that influence the success of individual teams There are no data regarding the sustainability of improvements
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| ZonMw grant no 945-14-405 | None | None | None |